The store will not work correctly when cookies are disabled.
N-benzyl-2-oxo-3-(2-oxoazetidin-1-yl)-1-(prop-2-ynyl)indoline-3-carboxamide
ID: ALA4874385
PubChem CID: 164626763
Max Phase: Preclinical
Molecular Formula: C22H19N3O3
Molecular Weight: 373.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: C#CCN1C(=O)C(C(=O)NCc2ccccc2)(N2CCC2=O)c2ccccc21
Standard InChI: InChI=1S/C22H19N3O3/c1-2-13-24-18-11-7-6-10-17(18)22(21(24)28,25-14-12-19(25)26)20(27)23-15-16-8-4-3-5-9-16/h1,3-11H,12-15H2,(H,23,27)
Standard InChI Key: QILRWZMLQSKQFZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
18.7665 -21.5606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9729 -22.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6496 -22.0441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8748 -22.6873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8737 -23.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5528 -23.8622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5510 -22.2991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2308 -22.6837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2310 -23.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9769 -23.7157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4399 -23.0784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2241 -23.0781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4097 -22.2486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6048 -21.4912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8515 -21.2961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7993 -22.9265 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4212 -20.9399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8972 -21.3023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6909 -20.4190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3526 -19.7987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2209 -20.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8822 -19.4440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6761 -18.5597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8027 -18.2983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1451 -18.9195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2296 -24.4928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6830 -25.1003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1342 -25.7102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 2 1 0
2 8 1 0
11 12 2 0
3 13 1 0
13 14 1 0
14 15 1 0
15 3 1 0
13 16 2 0
1 17 2 0
1 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
10 26 1 0
26 27 1 0
27 28 3 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 373.41 | Molecular Weight (Monoisotopic): 373.1426 | AlogP: 1.41 | #Rotatable Bonds: 5 |
Polar Surface Area: 69.72 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.36 | CX Basic pKa: ┄ | CX LogP: 1.32 | CX LogD: 1.32 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.49 | Np Likeness Score: -0.86 |
References
1. Brandão P, López Ó, Leitzbach L, Stark H, Fernández-Bolaños JG, Burke AJ, Pineiro M.. (2021) Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors., 12 (11.0): [PMID:34795859] [10.1021/acsmedchemlett.1c00344] |